Professor John CW Lim is founding Executive Director of the Centre of Regulatory Excellence (CoRE) at the Duke-National University of Singapore Medical School (Duke-NUS), and Policy Core Lead of the SingHealth Duke-NUS Global Health Institute (SDGHI).
A medical doctor with graduate degrees in Public Health from NUS and Health Policy and Management from Harvard University, Dr Lim is Professor of Practice at Duke-NUS and the NUS Saw Swee Hock School of Public Health, Senior Advisor at Singapore’s Ministry of Health (MOH), and Chairman of the Singapore Clinical Research Institute(SCRI).
Formerly Chief Executive Officer of Singapore’s Health Sciences Authority and Deputy Director of Medical Services (Industry & Research Matters) in MOH, Professor Lim has also held other senior positions in the health and education ministries. In his current roles, he draws on his international experience and networks to enhance capacity building and scientific excellence for issues related to health products regulation, health policies and health systems in Southeast Asia and the Asia-Pacific.
In the current COVID-19 pandemic, he is working with his colleagues in CoRE and SDGHI to provide advice, share knowledge, and facilitate collaborative discussions among international and national stakeholders on relevant issues to promote regulatory cooperation, including vaccines development and access.
He is a member of the Executive Board of the APEC Life Sciences Innovation Forum, Advisory Group of the US Pharmacopoeia’s Quality Institute, Scientific Advisory Council of the Centre for Innovation in Regulatory Science, ASEAN Diagnostics Development Initiative Strategic Planning Panel, St Andrew’s Mission Hospital Board and Board of the Singapore Food Agency.
In 2018, Professor Lim received the Drug Information Association’s Global Connector Inspire Award for leadership in promoting global collaboration to advance healthcare products to patients, and the Regulatory Affairs Professional Society’s highest Founder’s Award recognising substantial sustained impact in shaping regulatory practice and policy over the course of his career
he Centre of Regulatory Excellence (CoRE) was established in 2014 at the Duke-NUS Medical School in Singapore to support strengthening of health product regulatory systems in the Asia Pacific region, with a special focus on South-East Asia. Guided by its mission, CoRE contributes to improving patient access to health products, and enhancing regional health systems and health security. The Centre is gaining increasing recognition as a neutral, academic convener of dialogues, seminars and round tables involving international thought leaders in health regulation and healthcare systems. The centre offers a unique multi-pronged approach through key strategic approaches of administering education and training, conducting consultancy, and encouraging a think tank approach with an Asian perspective. As a trusted partner within a wide collaborative network of international and regional regulatory authorities, industry, non-governmental organisations and academic institutions, CoRE actively coordinates and contributes to regional capacity building and systems strengthening initiatives.